News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
282,436 Results
Type
Article (14235)
Company Profile (304)
Press Release (267897)
Section
Business (88093)
Career Advice (164)
Deals (14631)
Drug Delivery (34)
Drug Development (53160)
Employer Resources (31)
FDA (6242)
Job Trends (5763)
News (156981)
Policy (10629)
Tag
Academia (933)
Alliances (21769)
Alzheimer's disease (809)
Approvals (6227)
Artificial intelligence (71)
Bankruptcy (97)
Best Places to Work (5191)
Biotechnology (249)
Breast cancer (136)
Cancer (971)
Cardiovascular disease (75)
Career advice (142)
CAR-T (76)
Cell therapy (224)
Clinical research (42769)
Collaboration (321)
Compensation (131)
COVID-19 (1036)
C-suite (79)
Cystic fibrosis (68)
Data (1068)
Diabetes (91)
Diagnostics (1523)
Earnings (37215)
Events (51487)
Executive appointments (249)
FDA (6651)
Funding (310)
Gene editing (63)
Gene therapy (165)
GLP-1 (318)
Government (1143)
Healthcare (7229)
Infectious disease (1077)
Inflammatory bowel disease (102)
IPO (8320)
Job creations (894)
Job search strategy (136)
Layoffs (190)
Legal (1415)
Lung cancer (142)
Lymphoma (67)
Manufacturing (89)
Medical device (3413)
Medtech (3414)
Mergers & acquisitions (6459)
Metabolic disorders (265)
Neuroscience (1061)
NextGen Class of 2024 (2164)
Non-profit (948)
Northern California (1193)
Obesity (145)
Opinion (92)
Parkinson's disease (76)
Patents (62)
People (25354)
Phase I (14467)
Phase II (19526)
Phase III (13277)
Pipeline (398)
Postmarket research (1054)
Preclinical (6052)
Radiopharmaceuticals (206)
Rare diseases (206)
Real estate (1452)
Regulatory (8828)
Research institute (959)
Southern California (1044)
Startups (1980)
United States (9442)
Vaccines (176)
Weight loss (85)
Date
Today (4)
Last 7 days (401)
Last 30 days (1583)
Last 365 days (22092)
2024 (21986)
2023 (24102)
2022 (28342)
2021 (29415)
2020 (25120)
2019 (17928)
2018 (13064)
2017 (14772)
2016 (12725)
2015 (15499)
2014 (11218)
2013 (7986)
2012 (8223)
2011 (8298)
2010 (8032)
Location
Africa (151)
Asia (17637)
Australia (2952)
California (2674)
Canada (841)
China (205)
Colorado (99)
Connecticut (113)
Delaware (61)
Europe (38937)
Florida (289)
Georgia (79)
Illinois (168)
Indiana (90)
Maryland (344)
Massachusetts (2101)
Michigan (63)
Minnesota (113)
New Jersey (715)
New York (726)
North Carolina (447)
Northern California (1193)
Ohio (85)
Pennsylvania (535)
South America (236)
Southern California (1044)
Texas (314)
Washington State (267)
282,436 Results for "m6p therapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Silence Therapeutics to Present at Jefferies Global Healthcare Conference
Silence Therapeutics plc today announced the Company will present at the Jefferies Global Healthcare Conference on Thursday, June 6th at 2:30 p.m. ET.
May 30, 2024
·
1 min read
Biotech Bay
Apogee Therapeutics to Participate at the 2024 Bank of America Healthcare Conference
Apogee Therapeutics, Inc. announced that Michael Henderson, M.D., Chief Executive Officer and Jane Pritchett Henderson, Chief Financial Officer, will participate in a fireside chat at the 2024 Bank of America Healthcare Conference on Wednesday, May 15, 2024 at 3:40 p.m. P.T. / 6:40 p.m. E.T.
May 6, 2024
·
1 min read
Genetown
Monte Rosa Therapeutics to Present at the Jefferies Global Healthcare Conference
Monte Rosa Therapeutics, Inc. today announced that Markus Warmuth, M.D., Chief Executive Officer, will participate in a fireside chat at the Jefferies Global Healthcare Conference on Thursday, June 6, 2024, at 3:30 p.m. ET.
May 30, 2024
·
1 min read
Pharm Country
SpringWorks Therapeutics to Participate in the BofA Securities 2024 Health Care Conference
SpringWorks Therapeutics, Inc. announced that management will participate in a fireside chat at the BofA Securities 2024 Health Care Conference, taking place in Las Vegas, Nevada on Tuesday, May 14, 2024 at 3:40 p.m. PT / 6:40 p.m. ET.
May 8, 2024
·
1 min read
Genetown
Dyne Therapeutics to Present at Jefferies Global Healthcare Conference - May 30, 2024
Dyne Therapeutics, Inc today announced that management is scheduled to participate in a fireside chat at the Jefferies Global Healthcare Conference in New York on Thursday, June 6, 2024 at 3:00 p.m. ET.
May 30, 2024
·
1 min read
Genetown
Dianthus Therapeutics to Participate in the Jefferies Global Healthcare Conference
Dianthus Therapeutics, Inc. today announced its participation in the Jefferies Global Healthcare Conference. Marino Garcia, Chief Executive Officer, will present a corporate overview on Thursday, June 6, 2024 at 1:30 p.m. ET in New York.
May 30, 2024
·
4 min read
Drug Development
M6P Therapeutics Presents Promising Preclinical Data In Lysosomal Storage Disorders At The 19th Annual WORLDSymposium™ 2023
M6P Therapeutics, a privately held life sciences company developing next-generation enzyme replacement and gene therapies for lysosomal storage disorders, announced the presentation of promising preclinical data at the 19th Annual WORLDSymposium™, a research conference dedicated to lysosomal diseases being held in Orlando, FL, and virtually Feb. 22-26, 2023.
February 21, 2023
·
4 min read
BioMidwest
M6P Therapeutics Presents Novel AAV Gene Therapy Approach for the Treatment of Gaucher Disease at the ESGCT 29th Annual Congress
M6P Therapeutics Presents Novel AAV Gene Therapy Approach for the Treatment of Gaucher Disease at the ESGCT 29th Annual Congress.
October 11, 2022
·
4 min read
Genetown
Stoke Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference
Stoke Therapeutics, Inc. announced that management will present at the 42nd Annual J.P. Morgan Healthcare Conference on Wednesday, January 10, 2024, at 6:45 p.m. ET.
January 4, 2024
·
1 min read
Business
Enanta Pharmaceuticals to Host Conference Call on May 6 at 4:30 p.m. ET to Discuss its Financial Results for its Fiscal Second Quarter Ended March 31, 2024
Enanta Pharmaceuticals, Inc. today announced that it plans to report its financial results for its fiscal second quarter ended March 31, 2024, after the U.S. market closes on May 6, 2024.
April 29, 2024
·
1 min read
1 of 28,244
Next
